237 related articles for article (PubMed ID: 29426618)
1. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.
Rajjoub SR; Yan H; Calcatera NA; Kuchta K; Wang CE; Lutfi W; Moo-Young TA; Winchester DJ; Prinz RA
Surgery; 2018 May; 163(5):1134-1143. PubMed ID: 29426618
[TBL] [Abstract][Full Text] [Related]
2. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
[TBL] [Abstract][Full Text] [Related]
3. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Mainthia R; Wachtel H; Chen Y; Mort E; Parangi S; Sadow PM; Lubitz CC
Surgery; 2018 Jan; 163(1):60-65. PubMed ID: 29146229
[TBL] [Abstract][Full Text] [Related]
5. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Lim J; Kwon JS; Vriens MR; Clark OH; Shen WT; Gosnell JE; Suh I; Duh QY
Thyroid; 2016 Jun; 26(6):820-4. PubMed ID: 27083216
[TBL] [Abstract][Full Text] [Related]
6. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
7. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
8. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.
Adam MA; Pura J; Goffredo P; Dinan MA; Hyslop T; Reed SD; Scheri RP; Roman SA; Sosa JA
J Clin Endocrinol Metab; 2015 Jan; 100(1):115-21. PubMed ID: 25337927
[TBL] [Abstract][Full Text] [Related]
9. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
10. Low-risk differentiated thyroid cancer: the need for selective treatment.
Shaha AR; Shah JP; Loree TR
Ann Surg Oncol; 1997 Jun; 4(4):328-33. PubMed ID: 9181233
[TBL] [Abstract][Full Text] [Related]
11. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
[TBL] [Abstract][Full Text] [Related]
12. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
Kuo EJ; Thi WJ; Zheng F; Zanocco KA; Livhits MJ; Yeh MW
Thyroid; 2017 Dec; 27(12):1544-1549. PubMed ID: 29113553
[TBL] [Abstract][Full Text] [Related]
13. Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.
Golpanian S; Perez EA; Tashiro J; Lew JI; Sola JE; Hogan AR
Pediatr Surg Int; 2016 Mar; 32(3):201-8. PubMed ID: 26717936
[TBL] [Abstract][Full Text] [Related]
14. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
16. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
17. Multifocality of thyroid carcinomas: a "privilege" of papillary tumors or not?
Papageorgiou MS; Liratzopoulos N; Efremidou EI; Karanikas M; Minipoulos G; Manolas KJ
G Chir; 2010; 31(1-2):20-3. PubMed ID: 20298661
[TBL] [Abstract][Full Text] [Related]
18. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
[TBL] [Abstract][Full Text] [Related]
19. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
